Skip to content
Home » Oncology » Oncology – Misc » Retroperitoneal mass / sarcoma

Retroperitoneal mass / sarcoma

History:

  • Personal or familial history of malignancy, lymphoma
  • Hereditary syndromes – neurofibromatosis, MEN, Lynch, TSC, retinoblastoma, Li Fraumeni
  • Symptoms – abdominal, gastrointestinal, urinary, pain, endocrinopathies (paraganglioma)
  • Fertility / family planning
  • Medical co-morbidities – anticoagulation, immunosuppression, threats to future renal function, fitness for GA
  • Surgical history and prior procedures
  • Previous radiation therapy

 

Exam:

  • BMI, performance status, frailty
  • Blood pressure
  • Abdominal mass, scars, flank mass
  • Scrotal exam / pelvic exam / DRE
  • Lymphadenopathy
  • Stigmata of familial syndromes (neurofibromas)

 

Investigations:

  • Bloods
    • PSA, testis tumour markers, ovarian tumour markers
    • Plasma metanephrines
    • FBC / UEC / LFT / coags
  • Imaging
    • CT C/A/P with contrast gold standard
    • FDG PET / MRI in select cases
    • Scrotal ultrasound

CT findings in retroperitoneal tumours:

  • Fat presence (liposarcoma, lipoma, myelolipoma, AML)
  • Cystic or solid components
  • Other lymphadenopathy
  • Organ of origin
  • Other metastases
  • Visceral involvement or invasion
  • Vascular involvement or invasion
  • Feasibility of resection with margins

 

Biopsy?

  • If imaging is classic or suggestive of sarcoma, may proceed straight to surgical resection without biopsy
  • If MDT consensus for histology – retroperitoneal percutaneous CT guided biopsy with multiple passes in co-axial technique, aiming for solid viable components

 

Potential considerations for retroperitoneal mass surgery (and auxiliary surgery)

Right side

  • Duodenum
  • Liver – requiring mobilisation or resection, HPB involvement
  • Cava – requiring resection, graft, hepatic mobilisation
  • Adrenal vein

Left side

  • Spleen and tail of pancreas
  • Aorta

General masses:

  • Diaphragm involvement
  • Ureteric involvement – needing nephrectomy or ureteric stenting
  • Lumbar vessels
  • If inferior retroperitoneum – sympathetic chain, fertility or ejaculatory concerns

 

 

Retroperitoneal sarcoma

12 – 15 % of all sarcomas

Sarcomas arise from tissues of mesodermal origin.

One third of retroperitoneal masses

Typically incidental finding on imaging – can grow to large sizes without detection – mean 15 – 20 cm at diagnosis

Complete resection is only curative option – first operation is the best operation.

  • Aim is always for R0 resection – may require extensive resection of adjacent organs
  • MDT management mandatory – heterogenous group of diseases with different responses to radiation and chemotherapy
  • Even with complete R0 resection, often recurs.

 

Retroperitoneal tumour, particularly fat containing, if not clearly arising from kidney or adrenal, is a retroperitoneal sarcoma until proven otherwise.

 

Liposarcoma – may be well differentiated or dedifferentiated

Leiomyosarcoma – more common in younger patients

Other rarer types – solitary fibrous tumour, synovial sarcoma, Ewing’s sarcoma, malignant nerve sheath tumour

 

Neoadjuvant chemotherapy given for Ewing’s sarcoma.

Neoadjuvant and adjuvant radiation is case-by-case and being studied.

 

Sarcoma can also occur in spermatic cord, bladder, kidney.